3/5000 rhinoplasty
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjectively requiring rhinoplasty; 2. Aged 18 to 40 years, gender is not limited; 3. Subjects agree to participate in the clinical trial and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. People with a history of rhinoplasty; 2. Nasal deformity or defect caused by congenital or acquired injury; 3. Rich sebaceous glands in the nose or obvious skin inflammation in the nose; 4. Complicated with serious nasal diseases, such as allergic rhinitis, severe chronic atrophic rhinitis, hypertrophic turbinate, etc.; Nasal functional diseases, such as smelly nose disease, phantom smell and other abnormal smell; 5. CT images indicate deformity of the nose or difficult bone removal of chest ribs; 6. Uncontrolled facial or systemic infection; 7. Pregnant and lactating women; 8. People with allergies and scarring with two or more drug/food allergies; 9. Subjects with fasting blood glucose (venous) greater than 7.0mmol/L; 10. Patients with coagulation dysfunction; 11. People who are taking hormone drugs or taking hormone drugs for a long time; 12. Patients with autoimmune diseases, malignant tumors, tuberculosis and other serious basic diseases; 13. Patients with serious cardiovascular and cerebrovascular diseases; 14. People with mental illness or mental disorder; 15. abnormal liver and kidney function (ALT, AST, Cr, BUN any above the upper limit of the normal value); 16. Subjects who participated in or plan to participate in clinical studies of other drugs or medical devices within 3 months before the screening visit; 17. Other conditions deemed unsuitable for inclusion by the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| satisfaction; | — |
Countries
China